Bausch Health Companies (BHC) Inventory (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Inventory came in at $1.6 billion in Q2 2026, down 3.2% year-over-year from $1.7 billion in Q2 2025, and little changed quarter-over-quarter from $1.6 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Inventory (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Inventory across 18 years of filings, most recently posting $1.6 billion for Q2 2026.
- In Q2 2026, Inventory fell 3.2% year-over-year to $1.6 billion; the TTM figure through Jun 2026 stood at $1.6 billion (down 3.2% YoY), while the FY2025 annual figure was $1.6 billion, up 2.13% from the prior year.
- Inventory came in at $1.6 billion for Q2 2026 at Bausch Health Companies, roughly flat from $1.6 billion in the prior quarter.
- In the past five years, Inventory ranged from a high of $1.7 billion in Q3 2024 to a low of $1.0 billion in Q1 2022.
- Average Inventory over 5 years is $1.4 billion, with a median of $1.6 billion recorded in 2024.
- Year-over-year, Inventory soared 41.65% in 2023 and fell 3.44% in 2025.
- Over 5 years, Inventory stood at $1.1 billion in 2022, then soared by 41.65% to $1.5 billion in 2023, then climbed by 3.3% to $1.6 billion in 2024, then advanced by 2.13% to $1.6 billion in 2025, then declined by 1.66% to $1.6 billion in 2026.
- Per Business Quant data, the three most recent Inventory figures were $1.6 billion in Q2 2026, $1.6 billion in Q1 2026, and $1.6 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 3.22 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 3.93 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 850.02 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 677.95 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 1.60 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 226.55 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 143.15 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 179.91 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60 Bn |
| Mar 31, 2026 | 1.60 Bn |
| Dec 31, 2025 | 1.63 Bn |
| Sep 30, 2025 | 1.60 Bn |
| Jun 30, 2025 | 1.66 Bn |
| Mar 31, 2025 | 1.61 Bn |
| Dec 31, 2024 | 1.60 Bn |
| Sep 30, 2024 | 1.66 Bn |
| Jun 30, 2024 | 1.61 Bn |
| Mar 31, 2024 | 1.64 Bn |
| Dec 31, 2023 | 1.54 Bn |
| Sep 30, 2023 | 1.27 Bn |
| Jun 30, 2023 | 1.24 Bn |
| Mar 31, 2023 | 1.22 Bn |
| Dec 31, 2022 | 1.09 Bn |
| Sep 30, 2022 | 1.06 Bn |
| Jun 30, 2022 | 1.07 Bn |
| Mar 31, 2022 | 1.05 Bn |
| Dec 31, 2021 | 993.00 Mn |
| Sep 30, 2021 | 1.06 Bn |